SCHEMBL3182148

SCHEMBL3182148

CCCNC(O)=S.NC(O)=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 3/20 0.36
MAPT P10636 2/20 0.36
ALOX12 P18054 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.36
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 3/20 0.34
EPHX1 P07099 1/20 0.33
CYP3A4 P08684 1/20 0.33
MCL1 Q07820 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
GRIN2D O15399 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Selenium SCHEMBL11490253 0.97 KMT2A (0.39) KMT2AKDM4EMAPTALOX12TDP1
SCHEMBL15610835 0.97 KMT2A (0.39) KMT2AKDM4EMAPTALOX12TDP1
Ethane SCHEMBL1286340 0.97 KMT2A (0.39) KMT2AKDM4EMAPTALOX12TDP1
SCHEMBL15611257 0.97 KMT2A (0.39) KMT2AKDM4EMAPTALOX12TDP1
Methane SCHEMBL1286328 0.97 KMT2A (0.39) KMT2AKDM4EMAPTALOX12TDP1
Methane SCHEMBL10572268 0.95 KMT2A (0.38) KMT2AKDM4EMAPTALOX12TDP1
Propylamine SCHEMBL11524260 0.93 KMT2A (0.37) KMT2AKDM4EMAPTALOX12TDP1
Trimethylammonium SCHEMBL15610775 0.93 KMT2A (0.37) KMT2AKDM4EMAPTALOX12TDP1
SCHEMBL687718 0.92
SCHEMBL7009582 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3003321-A2 USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRIAN TUMOR Del Mar Pharmaceuticals (CA) 2016-04-13 EP disclosed
WO-2014194312-A2 USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRIAN TUMOR DEL MAR PHARMACEUTICALS (CA) 2014-12-04 WO disclosed
US-7833331-B2 Non-toxic corrosion-protection pigments based on cobalt UNIVERSITY OF DAYTON (US) 2010-11-16 US disclosed
US-7789958-B2 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON (US) 2010-09-07 US disclosed
US-20090163628-A1 NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON COBALT STURGILL JEFFREY ALLEN 2009-06-25 US disclosed
US-7422793-B2 Non-toxic corrosion-protection rinses and seals based on rare earth elements UNIVERSITY OF DAYTON (US) 2008-09-09 US disclosed
US-7407711-B2 Non-toxic corrosion-protection conversion coats based on rare earth elements UNIVERSITY OF DAYTON (US) 2008-08-05 US disclosed
US-7294211-B2 Non-toxic corrosion-protection conversion coats based on cobalt UNIVERSITY OF DAYTON (US) 2007-11-13 US disclosed
US-7291217-B2 Non-toxic corrosion-protection pigments based on rare earth elements UNIVERSITY OF DAYTON (US) 2007-11-06 US disclosed
US-20070149673-A1 NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON MANGANESE STURGILL JEFFREY A 2007-06-28 US disclosed
US-20040011252-A1 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON 2004-01-22 US disclosed
US-20030234063-A1 Non-toxic corrosion-protection conversion coats based on cobalt DAYTON, UNIVERSITY OF 2003-12-25 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060191-A2 NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
EP-0433393-A4 TREATMENT OF DAMAGED BONE MARROW AND DOSAGE UNITS THEREFOR 1992-01-15 EP disclosed
EP-0433393-A1 TREATMENT OF DAMAGED BONE MARROW AND DOSAGE UNITS THEREFOR. UNIV ROCHESTER (US) 1991-06-26 EP disclosed
WO-1991005571-A1 METHOD FOR PRODUCING BONE MARROW GROWTH CELL FACTORS UNIVERSITY OF ROCHESTER (US) 1991-05-02 WO disclosed
WO-1990002550-A1 TREATMENT OF DAMAGED BONE MARROW AND DOSAGE UNITS THEREFOR UNIVERSITY OF ROCHESTER (US) 1990-03-22 WO disclosed